Regeneron ‘Shocked’ At Biogen Lucentis Biosimilar Sales
Biogen’s Byooviz Biosimilar Launched 1 July; Company Stressed Gradual Launch
With its own interests in the branded eye-disease space, Regeneron has commented on ranibizumab biosimilar sponsor Biogen’s fortunes during a recent conference.
